Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-25 @ 5:26 PM
Study NCT ID:
NCT06009250
Status:
UNKNOWN
Last Update Posted:
2023-08-24
First Post:
2023-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
Sponsor:
Muhammad Ameen Abdelrady Abdelaziz
Organization:
Study Overview
Official Title:
Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut
Status:
UNKNOWN
Status Verified Date:
2023-08
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients
The main question\[s\] it aims to answer are:
* \[question 1\] prevalence of NAFLD in CKD patients.
* \[question 2\] the relationship between NAFLD and CKD.
The main question\[s\] it aims to answer are:
* \[question 1\] prevalence of NAFLD in CKD patients.
* \[question 2\] the relationship between NAFLD and CKD.
Detailed Description:
The goal of this observational study is to detect the prevalence of NAFLD in CKD patients
The main question\[s\] it aims to answer are:
* \[question 1\] prevalence of NAFLD in CKD patients.
* \[question 2\] the relationship between NAFLD and CKD.
The main question\[s\] it aims to answer are:
* \[question 1\] prevalence of NAFLD in CKD patients.
* \[question 2\] the relationship between NAFLD and CKD.
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: